...
首页> 外文期刊>Current bioactive compounds >Improved Solubility of Itraconazole Binary Dispersions using Neem Gum: Development and Characterization of Topical Gel
【24h】

Improved Solubility of Itraconazole Binary Dispersions using Neem Gum: Development and Characterization of Topical Gel

机译:使用Neem Gum的伊唑康唑二元分散体的溶解性:局部凝胶的开发和表征

获取原文
获取原文并翻译 | 示例

摘要

Background: Itraconazole is a triazole derivative and possesses structural similarities to theazole group (imidazoles and triazoles). It is a broad spectrum fungistatic. It belongs to BCS class IIcategory i.e. it has poor solubility and high permeability.Objective: Dissolution enhancement of poorly soluble itraconazole using purified neem gum as a naturalcarrier via binary dispersions and other methods was studied. Topical gel formulations of binary dispersionswere developed and evaluated for in vitro and in vivo antifungal activity.Methods: Five batches of solid dispersions (SD1-SD5) in various ratios of drug: neem gum were preparedby the solvent evaporation technique. Other mixtures were also prepared by kneading, cogrinding,physical mixing methods and evaluated further. Topical gel formulations were further developedand evaluated for antifungal activity (both in vitro and in vivo).Results: Equilibrium solubility studies of various mixtures indicated SD3 (1:3) as the optimum batchout of all solid dispersion batches. Equilibrium solubility studies of mixtures (KM, CGM, PM, SM)indicated significant solubility enhancement of kneading mixture in comparison to other mixtures. FTIRstudies indicated no interaction of the drug to the polymer. DSC, SEM and XRD studies indicated atransition from crystalline to the amorphous state of the drug. SD3 batch showed remarkably improveddissolution characteristics (100% drug release in 1.5 h) in comparison to the pure drug (38% in 2h).Further, the topical gel of SD3 was evaluated for in vitro diffusion, in vitro and in vivo antifungal activity.Sustained drug release (53% in 24 h) was observed in SD3 based gel formulation which is significantlyhigher than that in comparison to pure drug based gel (30% in 24 h). The increased area of zoneof inhibition of SD3 based gel indicated better antifungal activity of the SD3 gel formulation. Furtherhistopathology examination of skin specimens indicated enhanced efficacy of SD3 based gel in comparisonto pure drug based gel.Conclusion: Solid dispersion based topical gel formulation exhibits better antifungal activity in comparisonto pure drug based gel.
机译:背景:Itraconazole是三唑衍生物,并具有与Theazole Group(咪唑和三唑)的结构相似之处。它是一种广泛的谱稳定性。它属于BCS类IICALEGORY I.E.它具有较差的溶解性和高渗透性。研究了使用纯化的NEEM GUM作为通过二元分散体和其他方法的纯化的NEEM胶的溶解增强。在体外和体内抗真菌活性开发和评估的二元分散液的局部凝胶制剂。方法:溶剂蒸发技术制止了药物的各种比例的五批固体分散体(SD1-SD5):溶剂蒸发技术。还通过捏合,加强,物理混合方法并进一步评价来制备其他混合物。进一步发育局部凝胶制剂和评估用于抗真菌活性(体外和体内)的分析。结果:各种混合物的平衡溶解度研究表明SD3(1:3)为所有固体分散批次的最佳批量。与其他混合物相比,混合物的混合物(KM,CGM,PM,SM)的平衡溶解度研究表明了捏合混合物的显着溶解性。 FTIRSTUDIES表示没有药物对聚合物的相互作用。 DSC,SEM和XRD研究表明从结晶到药物的无定形状态。与纯药物相比,SD3批量显示出显着改善的矫正特征(1.5小时内100%药物释放)(38%,2h)。果实,评价SD3的局部凝胶,用于体外扩散,体外和体内抗真菌活性。在基于SD3的凝胶制剂中观察到持续的药物释放(24小时53%),其比与纯药物的凝胶相比显着高于其(24小时的30%)。基于SD3的凝胶的抑制区域的增加表明了SD3凝胶制剂的更好的抗真菌活性。较突主义的病理学检查皮肤检测表明,基于SD3的凝胶在比较纯药物基凝胶中提高了疗效。结论:固体分散基的局部凝胶制剂在比较纯药物基凝胶中表现出更好的抗真菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号